Clinical Trials
3 trialsNCT04973930 2025-05-13
IPT
New York State Psychiatric Institute
Phase 3 Suspended
NCT02037529 2024-08-20
Eribulin Mesylate or Paclitaxel as First- or Second-Line Therapy in Treating Patients With Recurrent Stage IIIC-IV Breast Cancer
Academic and Community Cancer Research United
Phase 3 Suspended
NCT00002696 2013-08-02
Combination Chemotherapy in Treating Women With Stage III Breast Cancer
National Cancer Institute (NCI)
Phase 3 Suspended